These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19416959)

  • 41. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
    Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.
    Saunders LP; Cao W; Chang WC; Albright RA; Braddock DT; De La Cruz EM
    J Biol Chem; 2011 Aug; 286(34):30130-41. PubMed ID: 21719699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
    Federico L; Pamuklar Z; Smyth SS; Morris AJ
    Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors.
    North EJ; Howard AL; Wanjala IW; Pham TC; Baker DL; Parrill AL
    J Med Chem; 2010 Apr; 53(8):3095-105. PubMed ID: 20349977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.
    Liu S; Umezu-Goto M; Murph M; Lu Y; Liu W; Zhang F; Yu S; Stephens LC; Cui X; Murrow G; Coombes K; Muller W; Hung MC; Perou CM; Lee AV; Fang X; Mills GB
    Cancer Cell; 2009 Jun; 15(6):539-50. PubMed ID: 19477432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.
    Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H
    J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
    Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
    J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclic phosphatidic acid is produced by autotaxin in blood.
    Tsuda S; Okudaira S; Moriya-Ito K; Shimamoto C; Tanaka M; Aoki J; Arai H; Murakami-Murofushi K; Kobayashi T
    J Biol Chem; 2006 Sep; 281(36):26081-8. PubMed ID: 16837466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.
    Pamuklar Z; Federico L; Liu S; Umezu-Goto M; Dong A; Panchatcharam M; Fulkerson Z; Berdyshev E; Natarajan V; Fang X; van Meeteren LA; Moolenaar WH; Mills GB; Morris AJ; Smyth SS
    J Biol Chem; 2009 Mar; 284(11):7385-94. PubMed ID: 19139100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal.
    Ferry G; Giganti A; Cogé F; Bertaux F; Thiam K; Boutin JA
    FEBS Lett; 2007 Jul; 581(18):3572-8. PubMed ID: 17628547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Significance of serum autotaxin activity in gastrointestinal disease].
    Ikeda H; Watanabe N; Nakamura K; Kume Y; Nakai Y; Fujishiro M; Omata M; Igarashi K; Yokota H; Yatomi Y
    Rinsho Byori; 2009 May; 57(5):445-9. PubMed ID: 19522250
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deficiency of autotaxin/lysophospholipase D results in head cavity formation in mouse embryos through the LPA receptor-Rho-ROCK pathway.
    Koike S; Keino-Masu K; Masu M
    Biochem Biophys Res Commun; 2010 Sep; 400(1):66-71. PubMed ID: 20692235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
    Ferguson CG; Bigman CS; Richardson RD; van Meeteren LA; Moolenaar WH; Prestwich GD
    Org Lett; 2006 May; 8(10):2023-6. PubMed ID: 16671772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific increase in serum autotaxin activity in patients with pancreatic cancer.
    Nakai Y; Ikeda H; Nakamura K; Kume Y; Fujishiro M; Sasahira N; Hirano K; Isayama H; Tada M; Kawabe T; Komatsu Y; Omata M; Aoki J; Koike K; Yatomi Y
    Clin Biochem; 2011 Jun; 44(8-9):576-81. PubMed ID: 21439952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Secretion and role of autotaxin and lysophosphatidic acid in adipose tissue].
    Saulnier-Blache JS
    J Soc Biol; 2006; 200(1):77-81. PubMed ID: 17144165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
    Panupinthu N; Lee HY; Mills GB
    Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two pathways for lysophosphatidic acid production.
    Aoki J; Inoue A; Okudaira S
    Biochim Biophys Acta; 2008 Sep; 1781(9):513-8. PubMed ID: 18621144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia.
    Khurana S; Tomar A; George SP; Wang Y; Siddiqui MR; Guo H; Tigyi G; Mathew S
    Exp Cell Res; 2008 Feb; 314(3):530-42. PubMed ID: 18054784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells.
    Gaetano CG; Samadi N; Tomsig JL; Macdonald TL; Lynch KR; Brindley DN
    Mol Carcinog; 2009 Sep; 48(9):801-9. PubMed ID: 19204929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.